Navigation Links
Caption in Medical News

Furious Reaction to insensitive Caption of the Picture of Abandoned Baby Girl

Several Australian feminists have denounced Telegraph, a popular daily, for carrying a large picture of an abandoned infant girl and a caption alongside , How could she? The all too obvious reference to the mother who abandoned the girl, for whatever reason, has infuriated many who say the...

ThermoGenesis Announces Launch of Res-Q System; New Device Expands Company's Presence in Bone Marrow Sector

...of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you shou...

Cambrex Reports Second Quarter 2009 Results

...ble raw materials or packaging materials, the Company's ability to receive regulatory approvals for its products and other factors described under the caption "Risk Factors That May Affect Future Results" in the Company's Quarterly Report on Form 10-Q for the period ending March 31, 2009. Any forward-lookin...

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS." The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to public...

BioMarin Announces Second Quarter 2009 Financial Results

...ose factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K, and the factors contained in BioMarin's reports on Form 10-Q. Stockholders are urged not...

Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan

...ose factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K, as amended, and the factors contained in BioMarin's reports on Form 10-Q and Form 8-K. S...

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). Copies of PharmAthene's public di...

The Hispanic got milk? Campaign Visited New York July 18 - July 22

... for two to New York City for 3 nights and $500 for expenses. Photo caption 1: Recovering with Milk... Jacque Vasquez and Cindy Lune drink their... them refuel after a workout, for less than 25 cents a glass. Photo caption 2: Milk Rocks!... Juan Vargas makes a pit stop at the Milk Mustache ...

Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...
Caption in Medical Technology

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

...its product candidates and its discoveries. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's annual report on Form 10-K for the year ended December 31, 2008 and the Quarterly Report on Form 10-Q for the quarter ...

Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders

...d Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2008, under the caption "Risk Factors." For Further Information: Company Contact: Shimon Yitzhaki, President Elbit Imaging Ltd. Tel: +972-3-608-6000...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

...sion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

ThermoGenesis Announces National Institute of Health Grant

...of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you shou...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

... be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, there can be no assurance...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

... be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, even with today's submissio...

NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds

...terially from those projected in the forward-looking statements in this press release, are detailed in NovaBay's Annual Report on Form 10-K, under the caption "Risk Factors" in Item 1A of Part I of that report, which was filed with the Securities and Exchange Commission on March 31, 2009. For more ...

BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

...ose factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K. Stockholders are urged not to place undue reliance on forward-looking statements, which ...
Caption in Biological Technology

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you shou...

ThermoGenesis Provides Update on Fiscal 2009 Results

...of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you shou...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

...dditional risks are described in greater detail in the reports Nile files with Securities and Exchange Commission, including those described under the caption "Risk Factors" in Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2008 filed with the Securities and Exchange Commission on ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...tions that could increase the rate of our cash consumption, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). We have based our projection of future ca...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...sion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

Caliper Life Sciences Reports Second Quarter 2009 Results

...perating expenses, enhance gross margins and improve efficiencies within Caliper. Further information on risks faced by Caliper are detailed under the caption "Risks Related To Our Business" in Caliper's Annual Report on Form 10-K for the year ended December 31, 2008. Our filings are available on a web site ...

Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results

...its product candidates and its discoveries. These and other risks which may impact management's expectations are described in greater detail under the caption "Risk Factors" in the company's annual report on Form 10-K for the year ended December 31, 2008 and the Quarterly Report on Form 10-Q for the quarter ...

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

...ssion, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commi...

Nile Therapeutics, Inc. Completes $3.4 Million Private Placement

...dditional risks are described in greater detail in the reports Nile files with Securities and Exchange Commission, including those described under the caption "Risk Factors" in Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2008 filed with the Securities and Exchange Commission on ...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

... 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in Wyeth's Annual Report on Form 10-K for the year ...m 6-K and Annual Report on Form 20-F, particularly the discussion under the caption "Item 3D, Risk Factors" in Elan's Annual Report on Form 20-F for the year e...
Other Tags
(Date:7/29/2014)... NY (PRWEB) July 29, 2014 The National ... have sent a letter to Washington NFL team owner Dan ... opposition to the R-word racial slur is emanating from “well-intentioned ... team and Snyder have yet to respond. , ... full text of the letter, which was first reported ...
(Date:7/29/2014)... Los Angeles, CA (PRWEB) July 29, 2014 ... of the temporary fix provided by energy drinks. ... boost in cognitive nutrition that creates optimal conditions for ... the brain healthy. truBrain hopes to raise $50,000 over ... provide a more stable mental boost and have compounding ...
(Date:7/29/2014)... The report “Filling Equipment Market by ... Aseptic, Net Weight), Process (Manual, Semi-Automatic, Automatic), Product ... & Forecast to 2019”, defines the filling equipment ... and cosmetic segments with analyses and projections of ... in terms of value. It also identifies the ...
(Date:7/29/2014)... York and London (PRWEB) July 29, 2014 ... focused provider of Computer Aided Engineering software, ... Device Innovation Consortium (MDIC), the first public-private partnership ... medical device community. MDIC made tremendous progress in ... players in the field of Computational Modeling ...
(Date:7/29/2014)... Florida (PRWEB) July 29, 2014 ... signs of tripling in the number of hospitals ... October 1, 2015 deadline, according to the recently ... and physician leaders, found in the reports “Top ... of hospitals now outsource Clinical documentation audit, review ...
Breaking Medicine News(10 mins):Health News:Native American Groups Urge Washington Team Owner Dan Snyder to Stop Claiming Name Change Issue Driven by "Elites" Who Are Not People of Color 2Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:CD-adapco Helps Advance the Use of Simulation in Medical Device Industry 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 2Health News:Clinical Documentation Improvement Heats Up as Half of US Hospitals Make 2015 Preparations for ICD-10, the Rest to Rely on Outsourcers, Black Book Survey Reveals 3
(Date:7/29/2014)... at a restaurant, don,t blame yourself; blame the menu. ... you want and more to do with a menu,s layout ... of over 300 diners, the Cornell study published this month ... that when it comes to what you order for dinner, ... and how you imagine it will taste. , First, any ...
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... "Global SaaS-based Business Intelligence (BI) Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The term BI refers ... providing access to, or analyzing information about a company,s ... the factors affecting their business; for example, metrics on ...
(Date:7/29/2014)... microorganisms, such as bacteria and spermatozoa, are subjected to ... exerted by the surrounding fluid. Such low-level inertia ... that the direction of propulsion made possible by such ... fluid. These findings have been published in EPJ ... and Atomic Energy Commission (CEA), in Le Barp, France, ...
Breaking Biology News(10 mins):Menu secrets that can make you slim by design 2Global SaaS-based Business Intelligence (BI) Market 2014-2018 2Optimum inertial self-propulsion design for snowman-like nanorobot 2
Other Contents